Cerebral amyloid angiopathy

I9_CEREBAMY

cerebral amyloid angiopathy: Hereditary cerebral hemorrhage with amyloidosis (HCHWA) describes a group of rare familial central nervous system disorders characterized by amyloid deposition in the cerebral blood vessels leading to hemorrhagic and non-hemorrhagic strokes, focal neurological deficits, and progressive cognitive decline eventually leading to dementia.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

124

4. Check minimum number of events

None

124

5. Include endpoints

None

124

6. Filter based on genotype QC (FinnGen only)

124

Control definitions (FinnGen only)

Control exclude
I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 791 364 421
Only index persons 742 344 398
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.02
Median age at first event (years)
Whole population 74.51 75.07 73.97
Only index persons 74.47 75.07 73.94

-FinnGen-

Key figures

All Female Male
Number of individuals 124 48 76
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 73.58 72.84 74.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
108
Matched controls
1080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
89.4
73
*
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
62.8
54
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
410.4
31.6
30
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
338.2
27.0
26
*
AA1AD
NOMESCO Finland
CT of head and brain
9.7
24.6
62
131
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
23.8
22
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
20.5
19
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
+∞
19.3
18
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
19.3
18
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
14.5
18.0
31
29
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.5
14.4
43
100
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
12.5
13.3
24
24
E85.9
ICD-10 Finland
Amyloidosis, unspecified
146.3
12.7
13
*
R4120
NOMESCO Finland
Occupational therapy
15.1
11.7
19
15
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.1
10.9
23
31
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
10.6
10
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
33.4
9.6
12
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
9.5
9
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
11.5
8.9
16
16
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
30.3
8.7
11
*
K90
ICPC
Stroke/cerebrovascular accident
24.2
8.2
11
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.3
7.8
24
55
R51.80
ICD-10 Finland
Headache
5.3
7.5
23
52
XA800
NOMESCO Finland
Neuropsychological investigation
17.3
7.4
11
7
N03AF02
ATC
oxcarbazepine; oral
13.3
7.3
12
10
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
21.8
7.3
10
5
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
32.4
7.3
9
*
N03AX14
ATC
levetiracetam; systemic
32.4
7.3
9
*
P20
ICPC
Memory disturbance
4.0
6.9
29
91
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
19.4
6.4
9
5
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
19.4
6.4
9
5
R41.0
ICD-10 Finland
Disorientation, unspecified
13.6
6.2
10
8
SPAT1229
SPAT
Assessment of need for aid
5.0
6.1
19
44

Mortality – FinRegistry

Association

Association between endpoint I9_CEREBAMY and mortality.

Females

Parameter HR [95% CI] p-value
I9_CEREBAMY 3.173 [1.99, 5.06] < 0.001
Birth year 0.996 [0.99, 1.0] 0.346

During the follow-up period (1.1.1998 — 31.12.2019), 96 out of 255 females with I9_CEREBAMY died.

Males

Parameter HR [95% CI] p-value
I9_CEREBAMY 3.149 [2.01, 4.93] < 0.001
Birth year 0.989 [0.98, 1.0] 0.018

During the follow-up period (1.1.1998 — 31.12.2019), 116 out of 278 males with I9_CEREBAMY died.

Mortality risk

Mortality risk for people of age

years, who have I9_CEREBAMY.

N-year risk Females Males
1 0.33% 0.564%
5 2.108% 3.809%
10 4.917% 9.085%
15 9.426% 16.378%
20 15.814% 27.056%

Relationships between endpoints

Index endpoint: I9_CEREBAMY – Cerebral amyloid angiopathy

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data